UPDATED Mar 28, 2024
Companies with a market cap of more than US$1B, strong financial health, modest PE ratios, past earnings growth and paying a dividend.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
HDB | €24.88 | 0.6% | 28.3% | €3.5b | €27.23 | PE8x | E6.9% | 5.6% | ||
3FY | UK£3.49 | 0% | n/a | UK£1.2b | UK£4.14 | PE18.3x | E6.5% | 3.6% | ||
3FY | UK£3.24 | -0.3% | -13.3% | UK£1.2b | UK£3.85 | PE18.3x | E6.5% | 3.6% | ||
DC7 | US$79.02 | 0% | -23.2% | US$31.1b | US$75.01 | PE10.9x | E8.1% | 2.3% | ||
46P1 | UK£7.82 | 0.8% | 33.6% | UK£1.4b | UK£8.78 | PE9.4x | E4.5% | 5.4% | ||
6P1 | AU$1.30 | 0% | 60.5% | AU$6.6b | AU$1.45 | PE15.5x | E9.0% | 6.2% | ||
ZOF | JP¥24.00 | 0% | 34.1% | JP¥1.1t | JP¥24.20 | PE12.6x | E7.1% | 3.8% | ||
EG0 | US$54.50 | 2.8% | 48.9% | US$6.3b | US$54.86 | PE9.1x | E2.3% | 1.9% | ||
RW5 | CA$38.36 | -1.2% | 29.1% | CA$22.1b | CA$39.91 | PE8.9x | E28.7% | 3.6% | ||
VIP | US$226.00 | 2.7% | 37.8% | US$1.8b | US$234.22 | PE13.5x | S1.0% | 3.1% | ||
AP0 | US$42.35 | 5.7% | 48.8% | US$3.6b | US$38.51 | PE15.6x | E8.1% | 6.1% | ||
FRK | US$27.54 | 0% | -10.9% | US$13.4b | US$22.33 | PE10.9x | E2.2% | 4.3% | ||
IVS | kr23.05 | -1.4% | 26.7% | kr819.8b | kr21.70 | PE6.4x | E-36.2% | 1.8% | ||
RW5 | CA$39.50 | 0% | 34.6% | CA$22.1b | CA$41.23 | PE8.9x | E28.7% | 3.6% | ||
IVSD | kr23.52 | 1.2% | 29.4% | kr819.8b | kr22.14 | PE6.4x | E-36.2% | 1.8% | ||
YBV0 | R$6.60 | -2.2% | 20.0% | R$67.5b | R$8.51 | PE16.3x | E11.6% | 3.2% | ||
CFX | US$132.00 | 0.8% | 51.5% | US$55.0b | US$133.65 | PE12x | E7.9% | 1.7% | ||
ENX | €16.90 | -0.6% | 27.1% | €9.4b | €18.10 | PE18.3x | E7.6% | 2.8% | ||
ENXB | €87.75 | 1.4% | 25.9% | €9.4b | €93.96 | PE18.3x | E7.6% | 2.8% | ||
CFX | US$137.00 | 6.2% | 58.1% | US$55.0b | US$134.63 | PE12.4x | E7.9% | 1.6% |